Jing Yuan

发表

A Robust Performance Degradation Modeling Approach Based on Student’s t-HMM and Nuisance Attribute Projection

Sen Wang, Han Yan, Yunfei Shao, 2020, IEEE Access.

A Method for Heterogeneous Spatio-Temporal Data Integration in Support of Marine Aquaculture Site Selection

Stephen Moore, Wei Liu, Kate Beard, 2020, Journal of Marine Science and Engineering.

Dual-Mode Noise-Reconstructed EMD for Weak Feature Extraction and Fault Diagnosis of Rotating Machinery

Haijiang Liu, Huiming Jiang, Jing Yuan, 2019, IEEE Access.

PF-04691502, a Potent and Selective Oral Inhibitor of PI3K and mTOR Kinases with Antitumor Activity

Aileen McHarg, Jing Yuan, Peter K. Vogt, 2011, Molecular Cancer Therapeutics.

Interfering with Resistance to Smoothened Antagonists by Inhibition of the PI3K Pathway in Medulloblastoma

Jing Yuan, William R. Sellers, Christoph Lengauer, 2010, Science Translational Medicine.

Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases

Ping Zhu, Gang Liu, Peter Fekkes, 2016, Nature.

Inhibition of NOTCH signaling by gamma secretase inhibitor engages the RB pathway and elicits cell cycle exit in T-cell acute lymphoblastic leukemia cells.

Xudong Dai, Theresa Zhang, Jing Yuan, 2009, Cancer research.

LncRNA LINC00173 enhances triple-negative breast cancer progression by suppressing miR-490-3p expression.

Jing Yuan, Yihui Ma, Jing Yuan, 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

An Integrated Genomic Approach to Identify Predictive Biomarkers of Response to the Aurora Kinase Inhibitor PF-03814735

Paul A. Rejto, Jing Yuan, Keith A. Ching, 2012, Molecular Cancer Therapeutics.

An F876L mutation in androgen receptor confers genetic and phenotypic resistance to MDV3100 (enzalutamide).

Joshua M. Korn, Ping Zhu, Sunkyu Kim, 2013, Cancer discovery.